🔎 Trials Near Me

Home › Kanser sa Pantog › District of Columbia › Washington

Pag-aaral pangklinika para sa Kanser sa Pantog sa Washington, DC

26 pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Washington (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Vanguard Study: Testing a New Way to Screen for Cancer

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Nagre-recruitPhase 3
  • Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07000084

Evaluation for NCI Surgery Branch Clinical Research Protocols

Nagre-recruitObservasyonal na pag-aaral
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT00001823

En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

Nagre-recruitObservasyonal na pag-aaral
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04235764

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 2 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT00026884

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Nagre-recruitPhase 2
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Nagre-recruitPhase 1/2
  • Sibley Memorial Hospital Pharmacy Department, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Nagre-recruitPhase 1
  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

Nagre-recruitPhase 3
  • Sibley Memorial Hospital ( Site 0849), Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3
  • MedStar Washington Hospital Center, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT02379429

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • National Institutes of Health, Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Nagre-recruitObservasyonal na pag-aaral
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT04923178

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Nagre-recruitPhase 1/2
  • The George Washington Medical Faculty Associates, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT04752722

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Nagre-recruitPhase 2/3
  • Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07106762

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Nagre-recruitPhase 2
  • Medstar Washington Hospital Center, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Nagre-recruitPhase 2
  • Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT05312671

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Nagre-recruitPhase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update May 19, 2026 · NCT06503146

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Cancer Support Community Research & Training Institute, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT02333604

Renal Retention in High Grade Upper Tract Urothelial Cancer

Nagre-recruitPhase 2
  • Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT05656235

Blue Light Cystoscopy With Cysview® Registry

Nagre-recruitObservasyonal na pag-aaral
  • Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT02660645

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

Nagre-recruit
  • Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Kalalakihan · Na-update Nob 18, 2025 · NCT05792722

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Nagre-recruitPhase 3
  • Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 18, 2025 · NCT06525571

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Silver Spring · 7 mi ang layo
  • Massive Bio SYNERGY-AI site, Bethesda · 7 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Gender Related Coping and Survivorship for Genitourinary Cancers

Nagre-recruitObservasyonal na pag-aaral
  • Sibley Memorial Hospital, Washington D.C.
Edad 18 pataas · Kababaihan · Na-update Okt 3, 2025 · NCT05649306

Pag-aaral para sa Kanser sa Pantog sa ibang lungsod

Iba pang pag-aaral sa Washington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.